Julie Shakib1, Karen Buchi1, Elizabeth Smith1, Paul C Young2. 1. Department of Pediatrics, University of Utah, Salt Lake City, UT. 2. Department of Pediatrics, University of Utah, Salt Lake City, UT. Electronic address: paul.young@hsc.utah.edu.
Abstract
OBJECTIVE: Current recommendations are that newborns of mothers with chorioamnionitis have a complete blood count, blood culture, and antibiotic therapy. We hypothesized that utilizing the early-onset sepsis (EOS) risk calculator and a clinical symptom assessment could safely reduce the number of newborns subjected to laboratory testing and antibiotics. METHODS: We reviewed 698 well-appearing newborns of estimated gestational age of ≥34 weeks born to mothers with chorioamnionitis. RESULTS: Sixty-five percent of newborns were managed according to the guidelines; 1 (0.14%) had culture-positive EOS. A strategy based on the use of the EOS calculator and clinical appearance of the newborn would have reduced the proportion having laboratory tests and antibiotics to 12% and would not have missed any cases of EOS. CONCLUSIONS: The EOS risk in well-appearing newborns of mothers with chorioamnionitis is low. Applying a strategy based on readily obtainable measures rather than the obstetrical diagnosis of chorioamnionitis would result in a substantial reduction of newborns undergoing laboratory tests and being exposed to antibiotics. Further prospective trials evaluating the safety of this approach are warranted.
OBJECTIVE: Current recommendations are that newborns of mothers with chorioamnionitis have a complete blood count, blood culture, and antibiotic therapy. We hypothesized that utilizing the early-onset sepsis (EOS) risk calculator and a clinical symptom assessment could safely reduce the number of newborns subjected to laboratory testing and antibiotics. METHODS: We reviewed 698 well-appearing newborns of estimated gestational age of ≥34 weeks born to mothers with chorioamnionitis. RESULTS: Sixty-five percent of newborns were managed according to the guidelines; 1 (0.14%) had culture-positive EOS. A strategy based on the use of the EOS calculator and clinical appearance of the newborn would have reduced the proportion having laboratory tests and antibiotics to 12% and would not have missed any cases of EOS. CONCLUSIONS: The EOS risk in well-appearing newborns of mothers with chorioamnionitis is low. Applying a strategy based on readily obtainable measures rather than the obstetrical diagnosis of chorioamnionitis would result in a substantial reduction of newborns undergoing laboratory tests and being exposed to antibiotics. Further prospective trials evaluating the safety of this approach are warranted.
Authors: Andrea N Trembath; Allison H Payne; Tarah T Colaizy; Edward F Bell; Michele C Walsh Journal: Semin Perinatol Date: 2016-09-13 Impact factor: 3.300
Authors: D Peterson; S B Hoffman; D El-Metwally; M Martino-Gomez; D R Chinta; C Hughes Driscoll Journal: J Perinatol Date: 2017-09-07 Impact factor: 2.521
Authors: Niek B Achten; J Wendelien Dorigo-Zetsma; Paul D van der Linden; Monique van Brakel; Frans B Plötz Journal: Eur J Pediatr Date: 2018-02-18 Impact factor: 3.183